How to design a drug for the disordered proteins?

Drug Discovery Today

Volumn 18, Issue 19-20, 2013, Pages 910-915

  Chen, Calvin Yu Chian ^a,b,c,d,e,f   Tou, Weng Ieong ^d,g  

^a ZHEJIANG UNIVERSITY   (China)

^b ASIA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f Massachusetts Institute of Technology Cambridge   (United States)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; INTRINSICALLY DISORDERED PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AB INITIO CALCULATION; CRYSTAL STRUCTURE; DRUG DESIGN; INTRINSICALLY DISORDERED REGION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; DRUG DESIGN; HUMANS; PHARMACEUTICAL PREPARATIONS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY;

EID: 84884586690     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.04.008     Document Type: Short Survey

References (66)

1. A.K. Dunker Function and structure of inherently disordered proteins Curr. Opin. Struct. Biol. 18 2008 756 764
2. A.K. Dunker Intrinsically disordered protein J. Mol. Graph. Model. 19 2001 26 59 (Pubitemid 32411501)
3. A.K. Dunker The unfoldomics decade: an update on intrinsically disordered proteins BMC Genet. 9 Suppl 2 2008 S1
4. C.J. Oldfield Coupled folding and binding with alpha-helix-forming molecular recognition elements Biochemistry 44 2005 12454 12470 (Pubitemid 41324337)
5. L. Pauling A theory of the structure and process of formation of antibodies J. Am. Chem. Soc. 62 1940 2643 2657
6. B.A. Shoemaker Speeding molecular recognition by using the folding funnel: the fly-casting mechanism Proc. Natl. Acad. Sci. U.S.A. 97 2000 8868 8873 (Pubitemid 30626639)
7. V.N. Uversky Why are 'natively unfolded' proteins unstructured under physiologic conditions? Proteins 41 2000 415 427
8. J. Gsponer Tight regulation of unstructured proteins: from transcript synthesis to protein degradation Science 322 2008 1365 1368 (Pubitemid 352775246)
9. A.K. Dunker Protein disorder and the evolution of molecular recognition: theory, predictions and observations Pac. Symp. Biocomput. 1998 473 484
10. A.K. Dunker Flexible nets. The roles of intrinsic disorder in protein interaction networks FEBS J. 272 2005 5129 5148 (Pubitemid 41503146)
11. A. Patil, and H. Nakamura Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks FEBS Lett. 580 2006 2041 2045
12. O. Schweers Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure J. Biol. Chem. 269 1994 24290 24297
13. M. Hollstein p53 mutations in human cancers Science 253 1991 49 53
14. P.H. Kussie Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain Science 274 1996 948 953 (Pubitemid 26398409)
15. V.N. Uversky Intrinsically disordered proteins in human diseases: introducing the D2 concept Annu. Rev. Biophys. 37 2008 215 246
16. Y. Cheng Rational drug design via intrinsically disordered protein Trends Biotechnol. 24 2006 435 442 (Pubitemid 44374778)
17. M.M. Babu Intrinsically disordered proteins: regulation and disease Curr. Opin. Struct. Biol. 21 2011 432 440
18. T. Mittag, and J.D. Forman-Kay Atomic-level characterization of disordered protein ensembles Curr. Opin. Struct. Biol. 17 2007 3 14 (Pubitemid 46240819)
19. D. Eliezer Biophysical characterization of intrinsically disordered proteins Curr. Opin. Struct. Biol. 19 2009 23 30
20. A. Bottger Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo Curr. Biol. 7 1997 860 869 (Pubitemid 27493125)
21. P. Chene A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines J. Mol. Biol. 299 2000 245 253
22. K.C. Chou, and N.Y. Chen The biological functions of low-frequency phonons Sci. Sin. 20 1977 447 457
23. K.C. Chou Identification of low-frequency modes in protein molecules Biochem. J. 215 1983 465 469
24. K.C. Chou, and B. Mao Collective motion in DNA and its role in drug intercalation Biopolymers 27 1988 1795 1815 (Pubitemid 18261785)
25. K.C. Chou Low-frequency collective motion in biomacromolecules and its biological functions Biophys. Chem. 30 1988 3 48
26. K.C. Chou Low-frequency motions in protein molecules. Beta-sheet and beta-barrel Biophys. J. 48 1985 289 297
27. K.C. Chou Low-frequency resonance and cooperativity of hemoglobin Trends Biochem. Sci. 14 1989 212 213
28. S.S. Chang Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine PLoS Comput. Biol. 7 2011 e1002315
29. S.C. Yang Identification of potent EGFR inhibitors from TCM Database@Taiwan PLoS Comput. Biol. 7 2011 e1002189
30. C.Y. Chen Mechanism of BAG1 repair on Parkinson's disease-linked DJ1 mutation J. Biomol. Struct. Dyn. 30 2012 1 12
31. J.J. Chou Solution structure of Ca(2+)-calmodulin reveals flexible hand-like properties of its domains Nat. Struct. Biol. 8 2001 990 997 (Pubitemid 33032370)
32. V. Daggett, and A. Fersht The present view of the mechanism of protein folding Nat. Rev. Mol. Cell Biol. 4 2003 497 502 (Pubitemid 36648595)
33. J.C. Phillips Scalable molecular dynamics with NAMD J. Comput. Chem. 26 2005 1781 1802 (Pubitemid 43078511)
34. D. Van der Spoel GROMACS: fast, flexible, and free J. Comput. Chem. 26 2005 1701 1718 (Pubitemid 43076182)
35. D.E. Shaw Anton, a special-purpose machine for molecular dynamics simulation Commun. ACM 51 2008 91 97
36. G.R. Bowman Network models for molecular kinetics and their initial applications to human health Cell Res. 20 2010 622 630
37. F. Noe, and S. Fischer Transition networks for modeling the kinetics of conformational change in macromolecules Curr. Opin. Struct. Biol. 18 2008 154 162
38. J.D. Chodera Automatic discovery of metastable states for the construction of Markov models of macromolecular conformational dynamics J. Chem. Phys. 126 2007 155101
39. V.A. Voelz Molecular simulation of ab initio protein folding for a millisecond folder NTL9(1-39) J. Am. Chem. Soc. 132 2010 1526 1528
40. G.R. Bowman Progress and challenges in the automated construction of Markov state models for full protein systems J. Chem. Phys. 131 2009 124101
41. F. Noe Constructing the equilibrium ensemble of folding pathways from short off-equilibrium simulations Proc. Natl. Acad. Sci. U.S.A. 106 2009 19011 19016
42. G.R. Bowman, and V.S. Pande Protein folded states are kinetic hubs Proc. Natl. Acad. Sci. U.S.A. 107 2010 10890 10895
43. C.B. Anfinsen The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain Proc. Natl. Acad. Sci. U.S.A. 47 1961 1309 1314
44. D. Baker A protein-folding reaction under kinetic control Nature 356 1992 263 265
45. K.T. Simons Assembly of protein tertiary structures from fragments with similar local sequences using simulated annealing and Bayesian scoring functions J. Mol. Biol. 268 1997 209 225 (Pubitemid 27192690)
46. K.T. Simons Improved recognition of native-like protein structures using a combination of sequence-dependent and sequence-independent features of proteins Proteins 34 1999 82 95 (Pubitemid 29019533)
47. R. Bonneau Rosetta in CASP4: progress in ab initio protein structure prediction Proteins 45 Suppl 5 2001 119 126 (Pubitemid 34113174)
48. R. Bonneau De novo prediction of three-dimensional structures for major protein families J. Mol. Biol. 322 2002 65 78 (Pubitemid 36132671)
49. P. Bradley Toward high-resolution de novo structure prediction for small proteins Science 309 2005 1868 1871 (Pubitemid 41325099)
50. S. Raman Structure prediction for CASP8 with all-atom refinement using Rosetta Proteins 77 Suppl 9 2009 89 99
51. S. Cooper Predicting protein structures with a multiplayer online game Nature 466 2010 756 760
52. F. Khatib Algorithm discovery by protein folding game players Proc. Natl. Acad. Sci. U.S.A. 108 2011 18949 18953
53. F. Khatib Crystal structure of a monomeric retroviral protease solved by protein folding game players Nat. Struct. Mol. Biol. 18 2011 1175 1177
54. V.N. Uversky Natively unfolded proteins: a point where biology waits for physics Prot. Sci. 11 2002 739 756 (Pubitemid 34241284)
55. A. Huang, and C.M. Stultz Conformational sampling with implicit solvent models: application to the PHF6 peptide in tau protein Biophys. J. 92 2007 34 45 (Pubitemid 46048414)
56. M.D. Mukrasch Highly populated turn conformations in natively unfolded Tau protein identified from residual dipolar couplings and molecular simulation J. Am. Chem. Soc. 129 2007 5235 5243 (Pubitemid 46651401)
57. J. Drews Drug discovery: a historical perspective Science 287 2000 1960 1964 (Pubitemid 30158662)
58. M.R. Arkin, and J.A. Wells Small-molecule inhibitors of protein-protein interactions: progressing towards the dream Nat. Rev. Drug Discov. 3 2004 301 317 (Pubitemid 38499758)
59. P.D. Renfrew Incorporation of noncanonical amino acids into Rosetta and use in computational protein-peptide interface design PLoS ONE 7 2012 e32637
60. T.J. Ritchie, and I.M. McLay Should medicinal chemists do molecular modelling? Drug Discov. Today 17 2012 534 537
61. G.R. Bowman, and P.L. Geissler Equilibrium fluctuations of a single folded protein reveal a multitude of potential cryptic allosteric sites Proc. Natl. Acad. Sci. U.S.A. 109 2012 11681 11686
62. V.N. Uversky Unfoldomics of human diseases: linking protein intrinsic disorder with diseases BMC Genet. 10 Suppl 1 2009 S7
63. N.A. Sallee The pathogen protein EspF(U) hijacks actin polymerization using mimicry and multivalency Nature 454 2008 1005 1008
64. S.J. Metallo Intrinsically disordered proteins are potential drug targets Curr. Opin. Chem. Biol. 14 2010 481 488
65. S.A. Yuzwa A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo Nat. Chem. Biol. 4 2008 483 490
66. Y. Zhang Inhibition of Wnt signaling by Dishevelled PDZ peptides Nat. Chem. Biol. 5 2009 217 219